Anna Protopapas's Net Worth
Estimate Recalculated Nov 5, 2024 07:11PM EST
Who is Anna Protopapas
Anna Protopapas has an estimated net worth of $6.83 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, Nuvalent, Inc., Mersana Therapeutics, Inc., Bioverativ Inc., ARIAD PHARMACEUTICALS INC, and MILLENNIUM PHARMACEUTICALS INC.
SEC CIK
Anna Protopapas's CIK is 0001347582
Past Insider Trading and Trends
2007 was Anna Protopapas's most active year for acquiring shares with 17 total transactions. Anna Protopapas's most active month to acquire stocks was the month of December. 2007 was Anna Protopapas's most active year for disposing of shares, totalling 29 transactions. Anna Protopapas's most active month to dispose stocks was the month of April. 2017 saw Anna Protopapas paying a total of $1,869,602.97 for 77,487 shares, this is the most they've acquired in one year. In 2008 Anna Protopapas cashed out on 443,879 shares for a total of $4,583,256.28, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
